» Articles » PMID: 23079522

Design, Synthesis and SAR Analysis of Novel Potent and Selective Small Molecule Antagonists of NPBWR1 (GPR7)

Overview
Specialty Biochemistry
Date 2012 Oct 20
PMID 23079522
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Novel small molecule antagonists of NPBWR1 (GPR7) are herein reported. A high-throughput screening (HTS) of the Molecular Libraries-Small Molecule Repository library identified 5-chloro-4-(4-methoxyphenoxy)-2-(p-tolyl)pyridazin-3(2H)-one as a NPBWR1 hit antagonist with micromolar activity. Design, synthesis and structure-activity relationships study of the HTS-derived hit led to the identification of 5-chloro-2-(3,5-dimethylphenyl)-4-(4-methoxyphenoxy)pyridazin-3(2H)-one lead molecule with submicromolar antagonist activity at the target receptor and high selectivity against a panel of therapeutically relevant off-target proteins. This lead molecule may provide a pharmacological tool to clarify the molecular basis of the in vivo physiological function and therapeutic utility of NPBWR1 in diverse disease areas including inflammatory pain and eating disorders.

Citing Articles

Evidence for Neuropeptide W Acting as a Physiological Corticotropin-releasing Inhibitory Factor in Male Chickens.

Liu M, Bu G, Wan Y, Zhang J, Mo C, Li J Endocrinology. 2022; 163(7).

PMID: 35583189 PMC: 9170129. DOI: 10.1210/endocr/bqac073.


Neuropeptide B/W receptor 1 peptidomimetic agonists: Structure-activity relationships and plasma stability.

Nguyen T, Decker A, Snyder R, Tonetti E, Gamage T, Zhang Y Eur J Med Chem. 2022; 231:114149.

PMID: 35101647 PMC: 8891040. DOI: 10.1016/j.ejmech.2022.114149.


SAR analysis of novel non-peptidic NPBWR1 (GPR7) antagonists.

Guerrero M, Urbano M, Schaeffer M, Brown S, Rosen H, Roberts E Bioorg Med Chem Lett. 2013; 23(3):614-9.

PMID: 23287738 PMC: 3621982. DOI: 10.1016/j.bmcl.2012.12.030.

References
1.
Hirashima N, Tsunematsu T, Ichiki K, Tanaka H, Kilduff T, Yamanaka A . Neuropeptide B induces slow wave sleep in mice. Sleep. 2011; 34(1):31-7. PMC: 3001792. DOI: 10.1093/sleep/34.1.31. View

2.
ODowd B, Scheideler M, Nguyen T, Cheng R, Rasmussen J, Marchese A . The cloning and chromosomal mapping of two novel human opioid-somatostatin-like receptor genes, GPR7 and GPR8, expressed in discrete areas of the brain. Genomics. 1995; 28(1):84-91. DOI: 10.1006/geno.1995.1109. View

3.
Date Y, Mondal M, Kageyama H, Ghamari-Langroudi M, Takenoya F, Yamaguchi H . Neuropeptide W: an anorectic peptide regulated by leptin and metabolic state. Endocrinology. 2010; 151(5):2200-10. DOI: 10.1210/en.2009-1153. View

4.
Romero F, Hastings N, Moningka R, Guo Z, Wang M, Di Salvo J . The discovery of potent antagonists of NPBWR1 (GPR7). Bioorg Med Chem Lett. 2011; 22(2):1014-8. DOI: 10.1016/j.bmcl.2011.11.126. View

5.
Zaratin P, Quattrini A, Previtali S, Comi G, Hervieu G, Scheideler M . Schwann cell overexpression of the GPR7 receptor in inflammatory and painful neuropathies. Mol Cell Neurosci. 2004; 28(1):55-63. DOI: 10.1016/j.mcn.2004.08.010. View